Double induction combined with tandem autologous stem cell transplantation in relapsed and refractory aggressive lymphomas.

被引：0
|
作者：
Reichle, A [1 ]
Berand, A [1 ]
Holler, E [1 ]
Andreesen, R [1 ]
机构：
[1] Univ Regensburg, D-8400 Regensburg, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2726
引用
收藏
页码：739A / 739A
页数：1
相关论文
共 50 条
  • [1] Double induction combined with tandem autologous stem cell transplantation in relapsed and refractory aggressive lymphoma
    Reichle, A
    Berand, A
    Holler, E
    Andreesen, R
    BONE MARROW TRANSPLANTATION, 2004, 33 : S246 - S247
  • [2] Treosulfan-based tandem high-dose chemo-immuno-therapy with autologous stem cell transplantation for relapsed and refractory aggressive B-cell lymphomas.
    Reichle, A
    Holler, E
    Berand, A
    Andreesen, R
    BLOOD, 2005, 106 (11) : 460B - 460B
  • [3] Autologous Stem Cell Transplantation for Aggressive Lymphomas
    Visani, Giuseppe
    Picardi, Paola
    Tosi, Patrizia
    Gonella, Roberta
    Loscocco, Federica
    Ricciardi, Teresa
    Malerba, Lara
    Guiducci, Barbara
    Tomassetti, Simona
    Barulli, Sara
    Isidori, Alessandro
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01)
  • [4] Rituximab Combined with BEAM and Autologous Stem Cell Transplantation for Older Patients with Relapsed Aggressive B-Cell Lymphomas
    Srour, Samer A.
    Khouri, Issa F.
    Lozano-Cerrada, Sara
    Nieto, Yago
    Alousi, Amin M.
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Hosing, Chitra
    BLOOD, 2016, 128 (22)
  • [5] Autologous stem cell transplantation (ASCT) for poor prognosis lymphomas.
    Nese, M
    Guillermo, C
    Díaz, L
    Isaurralde, H
    Grinberg, S
    Topolansky, L
    Buffano, G
    Perdomo, S
    Perdomo, A
    Lavagna, G
    BLOOD, 2002, 100 (11) : 479B - 479B
  • [6] Autologous stem cell transplantation as consolidation of first line response for aggressive non Hodgkin's lymphomas.
    Fanin, R
    Sperotto, A
    Geromin, A
    Cerno, M
    Stocchi, R
    Zaja, F
    Patriarca, F
    Silvestri, F
    Damiani, D
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S158 - S158
  • [7] ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMAS
    Na, Jihyun
    Kim, Juhyung
    Cho, Hee Jeong
    Ham, Ji Yeon
    Chang, Soon Hee
    Do, Young Rok
    Yea, Ji Woon
    Moon, Joon Ho
    Sohn, Sang Kyun
    Baek, Dong Won
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 347 - 347
  • [8] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY LYMPHOMAS IN CHILDHOOD: SINGLE CENTER EXPERIENCE
    Erbey, F.
    Atay, D.
    Akcay, A.
    Akbiyik, M.
    Ozturk, G.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S317 - S317
  • [9] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory lymphomas. Sixteen years experience of a single center
    Koumakis, G.
    Tsoukalas, N.
    Tryfonopoulos, D.
    Demiri, S.
    Vassilomanolakis, M.
    Barbounis, V.
    Droufakou, S.
    Filis, I.
    Moraki, M.
    Efremidis, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 353 - 353
  • [10] Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas.
    Schueler, Frank
    Hoffmann, Madelaine
    Pfrepper, Christian
    Daneschnejad, Said
    Lange, Thoralf
    Poenisch, Wolfram
    Al-Ali, Haifa K.
    Niederwieser, Dietger W.
    Basara, Nadezda
    BLOOD, 2010, 116 (21) : 1458 - 1458
12345